Suspended

Clinical Evaluation of 755nm Alexandrite Laser Versus Nanosecond 755nm Alexandrite

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

755nm Alexandrite Laser

+ 755nm Alexandrite Laser

Device
Who is being recruted

From 18 to 85 Years
+22 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: June 2012
See protocol details

Summary

Principal SponsorCynosure, Inc.
Last updated: February 5, 2014
Sourced from a government-validated database.Claim as a partner

Study start date: June 1, 2012

Actual date on which the first participant was enrolled.

Compare the efficacy of the 755nm Alexandrite laser to the nanosecond 755nm Alexandrite laser for the removal of unwanted tattoos using photographic evaluation and histological findings.

Principal SponsorCynosure, Inc.
Last updated: February 5, 2014
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 85 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

6 inclusion criteria required to participate
Has unwanted non-cosmetic tattoo(s) and wishes to undergo laser treatments

Is a healthy male or female between 18 and 85 years old?

Is willing to comply with all requirements of the study including being photographed, following post treatment care and attending all treatment and follow up visits

Is willing to consent to participate in the study

Show More Criteria

16 exclusion criteria prevent from participating
Allergic tattoos (hypersensitivity to tattoo ink)

Has any other reason determined by the physician to be ineligible to participate in the study

History of squamous cell carcinoma or melanoma

History of vitiligo or keloidal scarring

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
755nm Alexandrite Laser

Group II

Experimental
Nanosecond 755nm Alexandrite Laser

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Boston Va Medical Center

Boston, United StatesOpen Boston Va Medical Center in Google Maps
SuspendedOne Study Center